Related Experiment Video
Updated: Oct 5, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Molecular etiology of idiopathic cardiomyopathy in Asian populations
A Kimura1, M Ito-Satoh, T Hayashi
1Department of Molecular Pathogenesis, Division of Adult Diseases, Medical Research Institute, Tokyo Medical and Dental University, Kandasurugadai 2-3-10, Chiyoda-ku, Tokyo 101-0062, Japan.
Insights
Genetic analysis revealed mutations in sarcomere genes in hypertrophic cardiomyopathy (HCM) and Z-disc genes in dilated cardiomyopathy (DCM). Titin mutations were identified in HCM, suggesting cytoskeletal involvement in both conditions.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Etiology of Cardiomyopathy
Background:
- Idiopathic cardiomyopathy, including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), was historically of unknown cause.
- Recent research links HCM to sarcomere gene mutations (sarcomeropathy) and DCM to Z-disc component gene mutations (cytoskeletopathy).
Purpose of the Study:
- To investigate the genetic basis of HCM and DCM in a large Asian patient cohort.
- To identify novel disease-causing genes for cardiomyopathies.
Main Methods:
- Genetic analysis of known and candidate disease-related genes in familial and sporadic HCM and DCM cases.
- Comprehensive screening of all exons and adjacent introns of relevant genes.
Main Results:
- Sarcomere gene mutations identified in 47% of familial and 14% of sporadic HCM cases, with phenotype variations.
- Few mutations found in known DCM genes, but titin gene mutations were identified in HCM patients.
- Titin, a key protein linking Z-disc and sarcomere, mutations suggest cytoskeletal involvement in HCM.
Conclusions:
- Molecular etiologies are identifiable in approximately half of HCM cases and a subset of DCM cases.
- The findings suggest the existence of novel disease-causing genes for cardiomyopathies.
- HCM is partly a cytoskeletopathy, as evidenced by titin mutations.
Background:
Idiopathic cardiomyopathy was by definition a disease of unknown etiology and there are two major clinical forms, hypertrophic cardiomyopathy and dilated cardiomyopathy. Recent molecular genetic analyses have now revealed that mutations in genes for sarcomere cause hypertrophic cardiomyopathy leading to a hypothesis of hypertrophic cardiomyopathy as sarcomeropathy. On the other hand, mutations in genes for Z-disc component cause dilated cardiomyopathy speculating that dilated cardiomyopathy is cytoskeletopathy at least in part.
Methods:
A large panel of Asian patients and families with hypertrophic cardiomyopathy or dilated cardiomyopathy was analyzed for gene abnormalities in all exons and adjacent introns of the known disease-related genes and in a part of several candidates of novel disease-related genes.
Results:
Mutations in the genes for sarcomere were found in 47% of familial cases and 14% of sporadic cases of hypertrophic cardiomyopathy and there were locus and allelic differences in clinical phenotypes of hypertrophic cardiomyopathy patients. In contrast, only a few patients with dilated cardiomyopathy were identified for mutations in the known disease-causing genes. Mutations in the gene for titin, a giant molecule linking Z-disc with sarcomere components, were found in hypertrophic cardiomyopathy patients.
Conclusions:
The molecular etiologies of cardiomyopathy can be identified in about half of hypertrophic cardiomyopathy and a small part of dilated cardiomyopathy, suggesting that there are several novel disease-causing genes. Identification of titin mutation in hypertrophic cardiomyopathy indicate that hypertrophic cardiomyopathy is in part considered as the cytoskeletopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
